Product Information
SB 452533 is a small molecule that binds to the TRPV1 receptor and is used in cancer research. It has been shown to be a potent antagonist of the TRPV1 receptor in vivo, which may be due to its ability to inhibit the activation of cation channels. SB 452533 has also been shown to inhibit collagen-induced platelet aggregation and reduce the number of fibrinogen binding sites on platelets. SB 452533 is currently being investigated for its use in metabolic disorders due to its effect on reducing cholesterol levels and triglycerides.
Chemical properties
Technical inquiry about: 3D-JTA42939 SB 452533
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.